Fasting and post-prandial glycemia and their correlation with glycated hemoglobin in Type 2 diabetes

Journal of Endocrinological Investigation

Volumn 29, Issue 7, 2006, Pages 619-624

  Monami, M ^a   Lamanna, C ^a   Lambertucci, L ^a   Longo, R ^a   Cocca, C ^a   Addante, F ^a   Lotti, E ^a   Masotti, G ^a   Marchionni, N ^a   Mannucci, E ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Continuous glucose monitoring; Diabetes mellitus; Fasting glucosa; Glycated homoglobin; Home glucose self monitoring; Post prandial glucose

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FASTING BLOOD GLUCOSE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HOME MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; STATISTICAL SIGNIFICANCE;

EID: 33749018545     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344161     Document Type: Article

References (16)

1. American Diabetes Association. Standards of Medical Care in Diabetes-2006. Diabetes Care 2006, 29: S4-42.
2. Bonora E, Calcaterra F, Lombardi S, et al. Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care 2001, 24: 2023-9.
3. Trovati M, Ponziani MC, Massucco P, et al. Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions. Eur J Clin Invest 2002, 32: 179-86.
4. Bouma M, Dekker JH, de Sonnaville JJ, et al. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care 1999, 22: 904-7.
5. Avignon A, Radauceanu A, Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 1997,20: 1822-6.
6. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 2003, 26: 881-5.
7. Woerle HJ, Pimenta WP, Meyer C, et al. Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values. Arch Intern Med 2004, 164: 1627-32.
8. Mastrototaro J. The MiniMed continuos glucose monitoring system (CGMS). J Pediatr Endocrinol Metab 1999, 12: 751-8.
9. Ito C, Maeda R, Ishida S, Sasaki H, Harada H. Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c. Diabetes Res Clin Pract 2000, 50: 225-30.
10. Muggeo M, Zoppini G, Bonora E, et al. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care 2000, 23: 45-50.
11. Brichard SM, van den AE, Ketelslegers JM, Lambert AE. Home blood glucose monitoring, glycosylated hemoglobin and fructosamine: their relationships in diabetic patients with and without residual C-peptide secretion. Diabetes Metab 1989, 15: 388-393.
12. Gastaldelli A, Miyazaki Y, Pettiti M, et al. Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab 2002, 87: 5098-103.
13. Garca-Estevez DA, Araujo-Vilar D, Saavedra-Gonzalez A, Fiestras-Janeiro G, Cabezas-Cerrato J. Analysis of the relationship between body mass index, insulin resistance, and beta-cell function: a cross-sectional study using the minimal model. Metabolism 2004, 53: 1462-1466.
14. Lyssenko, V, Almgren P, Anevski D, et al. Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 2005, 54: 166-74.
15. Osei K, Rhinesmith S, Gaillard T, Schuster D. Impaired insulin sensitivity; insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. Diabetes Care 2004, 27: 1439-46
16. Vaccaro O, Ruffa G, Imperatore G, Iovino V, Rivellese AA, Riccardi G. Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care 1999, 22: 1490-3.